Effects of intensive blood-pressure control in type 2 diabetes mellitus

Cited by (158)

Items 101–158 of 158

1. Nine-year effects of 3.7 years of intensive glycemic control on cardiovascular outcomes
   The ACCORD Study Group · 2016 · Diabetes Care
2. Cognitive Function and Brain Structure in Persons With Type 2 Diabetes Mellitus After Intensive Lowering of Blood Pressure and Lipid Levels: A Randomized Clinical Trial
   Williamson, Jeff D., Launer, Lenore J., Bryan, R. Nick, Coker, Laura H., Lazar, Ronald M., Gerstein, Hertzel C., Murray, Anne M., Sullivan, Mark D., Horowitz, Karen R., Ding, Jingzhong et al. · 2014 · JAMA Internal Medicine
3. Comparative efficacy of glucose-lowering medications on body weight and blood pressure in patients with type 2 diabetes: a systematic review and network meta-analysis
   Tsapas, Apostolos, Karagiannis, Thomas, Kakotrichi, Panagiota, Avgerinos, Ioannis, Mantsiou, Chrysanthi, Tousinas, Georgios, Manolopoulos, Apostolos, Liakos, Aris, Malandris, Konstantinos, Matthews, David R. et al. · 2021 · Diabetes, Obesity and Metabolism
4. Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes
   Elam, Marshall B., Ginsberg, Henry N., Lovato, Laura C., Corson, Marshall, Largay, Joseph, Leiter, Lawrence A., Lopez, Carlos, O’Connor, Patrick J., Sweeney, Mary Ellen, Weiss, Daniel et al. · 2017 · JAMA Cardiology
5. Persistent Effects of Intensive Glycemic Control on Retinopathy in Type 2 Diabetes in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Follow-On Study
   The Action to Control Cardiovascular Risk in Diabetes Follow-On (ACCORDION) Eye Study Group and the Action to Control Cardiovascular Risk in Diabetes Follow-On (ACCORDION) Study Group · 2016 · Diabetes Care
6. Diabetes mellitus and stroke: A clinical update
   Tun, Nyo Nyo, Arunagirinathan, Ganesan, Munshi, Sunil K, Pappachan, Joseph M · 2017 · World Journal of Diabetes
7. The Polypill in the Prevention of Cardiovascular Diseases: Key Concepts, Current Status, Challenges, and Future Directions
   Lonn, Eva, Bosch, Jackie, Teo, Koon K., Pais, Prem, Xavier, Denis, Yusuf, Salim · 2010 · Circulation
8. Prevalence of Apparent Treatment-Resistant Hypertension among Individuals with CKD
   Tanner, Rikki M., Calhoun, David A., Bell, Emmy K., Bowling, C. Barrett, Gutiérrez, Orlando M., Irvin, Marguerite R., Lackland, Daniel T., Oparil, Suzanne, Warnock, David, Muntner, Paul · 2013 · Clinical Journal of the American Society of Nephrology
9. Masked Hypertension in Diabetes Mellitus: Treatment Implications for Clinical Practice
   Franklin, Stanley S., Thijs, Lutgarde, Li, Yan, Hansen, Tine W., Boggia, José, Liu, Yanping, Asayama, Kei, Björklund-Bodegård, Kristina, Ohkubo, Takayoshi, Jeppesen, Jørgen et al. · 2013 · Hypertension
10. Prevalence of Optimal Treatment Regimens in Patients With Apparent Treatment-Resistant Hypertension Based on Office Blood Pressure in a Community-Based Practice Network
    Egan, Brent M., Zhao, Yumin, Li, Jiexiang, Brzezinski, W. Adam, Todoran, Thomas M., Brook, Robert D., Calhoun, David A. · 2013 · Hypertension
11. Evidence-based practice guideline for the treatment for diabetes in Japan 2013
    Tajima, Naoko, Noda, Mitsuhiko, Origasa, Hideki, Noto, Hiroshi, Yabe, Daisuke, Fujita, Yukihiro, Goto, Atsushi, Fujimoto, Kei, Sakamoto, Masaya, Haneda, Masakazu · 2015 · Diabetology International
12. Psychosocial Factors in Diabetes and Cardiovascular Risk
    Hackett, Ruth A., Steptoe, Andrew · 2016 · Current Cardiology Reports
13. Blood Pressure and Cholesterol Control in Hypertensive Hypercholesterolemic Patients: National Health and Nutrition Examination Surveys 1988–2010
    Egan, Brent M., Li, Jiexiang, Qanungo, Suparna, Wolfman, Tamara E. · 2013 · Circulation
14. Implications of blood pressure measurement technique for implementation of systolic blood pressure intervention trial (SPRINT)
    Agarwal, Rajiv · 2017 · Journal of the American Heart Association
15. Empagliflozin and Cerebrovascular Events in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk
    Zinman, Bernard, Inzucchi, Silvio E., Lachin, John M., Wanner, Christoph, Fitchett, David, Kohler, Sven, Mattheus, Michaela, Woerle, Hans J., Broedl, Uli C., Johansen, Odd Erik et al. · 2017 · Stroke
16. Screening for type 2 diabetes mellitus: a systematic review for the U.S. Preventive Services Task Force
    Selph, Shelley, Dana, Tracy, Blazina, Ian, Bougatsos, Christina, Patel, Hetal, Chou, Roger · 2015 · Annals of Internal Medicine
17. Intensive and Standard Blood Pressure Targets in Patients With Type 2 Diabetes Mellitus: Systematic Review and Meta-analysis
    McBrien, Kerry, Rabi, Doreen M., Campbell, Norm, Barnieh, Lianne, Clement, Fiona, Hemmelgarn, Brenda R., Tonelli, Marcello, Leiter, Lawrence A., Klarenbach, Scott W., Manns, Braden J. · 2012 · Archives of Internal Medicine
18. Intensive systolic blood pressure control and incident chronic kidney disease in people with and without diabetes mellitus: secondary analyses of two randomised controlled trials
    Beddhu, Srinivasan, Greene, Tom, Boucher, Robert, Cushman, William C, Wei, Guo, Stoddard, Gregory, Ix, Joachim H, Chonchol, Michel, Kramer, Holly, Cheung, Alfred K et al. · 2018 · The Lancet Diabetes & Endocrinology
19. Effect of intensive blood pressure treatment on heart failure events in the systolic blood pressure reduction intervention trial
    Upadhya, Bharathi, Rocco, Michael, Lewis, Cora E., Oparil, Suzanne, Lovato, Laura C., Cushman, William C., Bates, Jeffrey T., Bello, Natalie A., Aurigemma, Gerard, Fine, Lawrence J. et al. · 2017 · Circulation: Heart Failure
20. 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026
    American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, Mandeep, McCoy, Rozalina G., Balapattabi, Kirthikaa, Bannuru, Raveendhara R., Bellini, Natalie J., Bennett, Allison K., Beverly, Elizabeth A., Briggs Early, Kathaleen, ChallaSivaKanaka, Sathyavathi et al. · 2026 · Diabetes Care
21. 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026
    American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, Mandeep, McCoy, Rozalina G., Balapattabi, Kirthikaa, Bannuru, Raveendhara R., Bellini, Natalie J., Bennett, Allison K., Beverly, Elizabeth A., Briggs Early, Kathaleen, ChallaSivaKanaka, Sathyavathi et al. · 2026 · Diabetes Care
22. Management of hyperglycemia, dyslipidemia, and albuminuria in patients with diabetes and CKD: A systematic review for a KDOQI clinical practice guideline
    Slinin, Yelena, Ishani, Areef, Rector, Thomas, Fitzgerald, Patrick, MacDonald, Roderick, Tacklind, James, Rutks, Indulis, Wilt, Timothy J. · 2012 · American Journal of Kidney Diseases
23. Timeline of History of Hypertension Treatment
    Saklayen, Mohammad G., Deshpande, Neeraj V. · 2016 · Frontiers in Cardiovascular Medicine
24. Prevalence, Predictors, and Outcomes in Treatment-resistant Hypertension in Patients with Coronary Disease
    Bangalore, Sripal, Fayyad, Rana, Laskey, Rachel, DeMicco, David A., Deedwania, Prakash, Kostis, John B., Messerli, Franz H. · 2014 · The American Journal of Medicine
25. Cardiovascular Risk of Resistant Hypertension: Dependence on Treatment-Time Regimen of Blood Pressure–Lowering Medications
    Ayala, Diana E., Hermida, Ramón C., Mojón, Artemio, Fernández, José R. · 2013 · Chronobiology International
26. Current Concepts in the Treatment of Renovascular Hypertension
    Herrmann, Sandra M, Textor, Stephen C · 2018 · American Journal of Hypertension
27. Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials
    Basu, Sanjay, Sussman, Jeremy B., Rigdon, Joseph, Steimle, Lauren, Denton, Brian T., Hayward, Rodney A. · 2017 · PLOS Medicine
28. 2020 Consensus summary on the management of hypertension in Asia from the HOPE Asia Network
    Kario, Kazuomi, Park, Sungha, Chia, Yook‐Chin, Sukonthasarn, Apichard, Turana, Yuda, Shin, Jinho, Chen, Chen‐Huan, Buranakitjaroen, Peera, Divinagracia, Romeo, Nailes, Jennifer et al. · 2020 · The Journal of Clinical Hypertension
29. The effects of mindfulness-based stress reduction on cardiac patients’ blood pressure, perceived stress, and anger: A single-blind randomized controlled trial
    Momeni, Javad, Omidi, Abdollah, Raygan, Fariba, Akbari, Hossein · 2016 · Journal of the American Society of Hypertension
30. Smart care based on telemonitoring and telemedicine for type 2 diabetes care: Multi-center randomized controlled trial
    Jeong, Ji Yun, Jeon, Jae-Han, Bae, Kwi-Hyun, Choi, Yeon-Kyung, Park, Keun-Gyu, Kim, Jung-Guk, Won, Kyu Chang, Cha, Bong Soo, Ahn, Chul Woo, Kim, Dong Won et al. · 2018 · Telemedicine and e-Health
31. Associations of Fenofibrate Therapy With Incidence and Progression of CKD in Patients With Type 2 Diabetes
    Frazier, Rebecca, Mehta, Rupal, Cai, Xuan, Lee, Jungwha, Napoli, Sara, Craven, Timothy, Tuazon, Jennifer, Safdi, Adam, Scialla, Julia, Susztak, Katalin et al. · 2019 · Kidney International Reports
32. BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial
    Leehey, David J., Zhang, Jane H., Emanuele, Nicholas V., Whaley-Connell, Adam, Palevsky, Paul M., Reilly, Robert F., Guarino, Peter, Fried, Linda F. · 2015 · Clinical Journal of the American Society of Nephrology
33. Association between Physical Activity Advice Only or Structured Exercise Training with Blood Pressure Levels in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
    Figueira, Franciele R., Umpierre, Daniel, Cureau, Felipe V., Zucatti, Alessandra T. N., Dalzochio, Mériane B., Leitão, Cristiane B., Schaan, Beatriz D. · 2014 · Sports Medicine
34. Type 2 diabetes and cardiovascular disease: what next?
    Joseph, Joshua J., Golden, Sherita Hill · 2014 · Current Opinion in Endocrinology, Diabetes & Obesity
35. Effects of Blood Pressure Lowering on Clinical Outcomes According to Baseline Blood Pressure and Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus: The ADVANCE Trial
    Rahman, Faisal, McEvoy, John W., Ohkuma, Toshiaki, Marre, Michel, Hamet, Pavel, Harrap, Stephen, Mancia, Giuseppe, Rodgers, Anthony, Selvin, Elizabeth, Williams, Bryan et al. · 2019 · Hypertension
36. Cardiovascular disease risk in an aging HIV population: not just a question of biology
    So-Armah, Kaku, Freiberg, Matthew S. · 2014 · Current Opinion in HIV and AIDS
37. Effects of intensive blood pressure lowering on mortality and cardiovascular and renal outcomes in type 2 diabetic patients: A meta-analysis
    Wang, Jing, Chen, Yalei, Xu, Weihao, Lu, Nianfang, Cao, Jian, Yu, Shengyuan · 2019 · PLOS ONE
38. Intensive blood pressure lowering in patients with and patients without type 2 diabetes: A pooled analysis from two randomized trials
    Brouwer, Tom F., Vehmeijer, Jim T., Kalkman, Deborah N., Berger, Wouter R., van den Born, Bert-Jan H., Peters, Ron J., Knops, Reinoud E. · 2018 · Diabetes Care
39. Effect of intensive blood pressure control in patients with type 2 diabetes mellitus over 9 years of follow-up: A subgroup analysis of high-risk ACCORDION trial participants
    Buckley, Leo F., Dixon, Dave L., Wohlford, George F., Wijesinghe, Dayanjan S., Baker, William L., Van Tassell, Benjamin W. · 2018 · Diabetes, Obesity and Metabolism
40. Low incidence of cardiovascular events in Japanese patients with Type 2 diabetes in primary care settings: a prospective cohort study (JDDM 20): Cardiovascular outcomes in Japanese Type 2 diabetes
    Yokoyama, H., Matsushima, M., Kawai, K., Hirao, K., Oishi, M., Sugimoto, H., Takeda, H., Minami, M., Kobayashi, M., Sone, H. et al. · 2011 · Diabetic Medicine
41. Benefits of intensive blood pressure treatment in patients with type 2 diabetes mellitus receiving standard but not intensive glycemic control
    Tsujimoto, Tetsuro, Kajio, Hiroshi · 2018 · Hypertension
42. Role of Aldosterone Blockade in Resistant Hypertension
    Egan, Brent M., Li, Jiexiang · 2014 · Seminars in Nephrology
43. Creatinine Rise During Blood Pressure Therapy and the Risk of Adverse Clinical Outcomes in Patients With Type 2 Diabetes Mellitus: A Post Hoc Analysis of the ACCORD-BP Randomized Controlled Trial
    Collard, Didier, Brouwer, Tom F., Peters, Ron J.G., Vogt, Liffert, van den Born, Bert-Jan H. · 2018 · Hypertension
44. Blood Pressure Control in Diabetes Mellitus: Is Lower Always Better, and How Low Should it Go?
    Deedwania, Prakash C. · 2011 · Circulation
45. Management of hypertension in patients with chronic kidney disease
    Hamrahian, Seyed Mehrdad · 2017 · Current Hypertension Reports
46. Optimal blood pressure thresholds for minimal coronary artery disease risk in type 1 diabetes
    Guo, Jingchuan, Brooks, Maria M., Muldoon, Matthew F., Naimi, Ashely I., Orchard, Trevor J., Costacou, Tina · 2019 · Diabetes Care
47. Measuring and managing blood pressure in a primary care setting: a pragmatic implementation study
    Doane, John, Buu, Jenni, Penrod, M. Jason, Bischoff, Michelle, Conroy, Molly B., Stults, Barry · 2018 · The Journal of the American Board of Family Medicine
48. Average Clinician‐Measured Blood Pressures and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Ischemic Heart Disease in the EXAMINE Trial
    White, William B., Jalil, Fatima, Cushman, William C., Bakris, George L., Bergenstal, Richard, Heller, Simon R., Liu, Yuyin, Mehta, Cyrus, Zannad, Faiez, Cannon, Christopher P. · 2018 · Journal of the American Heart Association
49. Personalised treatment targets in type 2 diabetes patients: The Dutch approach
    Boels, Anne Meike, Hart, Huberta E., Rutten, Guy E., Vos, Rimke C. · 2017 · Primary Care Diabetes
50. Blood pressure lowering and stroke events in type 2 diabetes: A network meta-analysis of randomized controlled trials
    Xie, Xiao-Xu, Liu, Peng, Wan, Fei-Yan, Lin, Shu-Guang, Zhong, Wen-Ling, Yuan, Zhao-Kang, Zou, Jiao-Jiao, Liu, Li-Bin · 2016 · International Journal of Cardiology
51. Integrating health data-driven machine learning algorithms to evaluate risk factors of early stage hypertension at different levels of HDL and LDL cholesterol
    Liao, Pen-Chih, Chen, Ming-Shu, Jhou, Mao-Jhen, Chen, Tsan-Chi, Yang, Chih-Te, Lu, Chi-Jie · 2022 · Diagnostics
52. Comparison of ambulatory blood pressure and clinic blood pressure in relation to cardiovascular diseases in diabetic patients
    Shen, Jian, Li, Zhi-Ming, He, Li-Zhen, Deng, Ren-Sheng, Liu, Jing-Guang, Shen, Yuan-Sheng · 2017 · Medicine
53. More Versus Less Blood Pressure Lowering: An Update
    Atkins, Emily R., Rodgers, Anthony · 2016 · Clinical Therapeutics
54. The Ongoing Saga of Optimal Blood Pressure Level in Patients With Diabetes Mellitus and Coronary Artery Disease
    Deedwania, Prakash · 2018 · Journal of the American Heart Association
55. Antihypertensive effect of the mineralocorticoid receptor antagonist eplerenone: a pooled analysis of patient-level data from comparative trials using regulatory-approved doses
    Fernet, Mireille, Beckerman, Bruce, Abreu, Paula, Lins, Katharina, Vincent, John, Burgess, Ellen · 2018 · Vascular Health and Risk Management
56. Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the academie study
    ACADEMIE Study Investigators, Imaizumi, Satoshi, Shiga, Yuhei, Ogawa, Masahiro, Sako, Hideto, Nagata, Yoshihisa, Matsunaga, Akira, Shirotani, Tetsuro, Hoshino, Fumihiro, Yahiro, Eiji et al. · 2019 · Heart and Vessels
57. Long‐term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study
    The Diabetes Prevention Program Outcomes Study Research Group; prepared on behalf of the DPPOS Research Group, Orchard, T. J., Temprosa, M., Barrett‐Connor, E., Fowler, S. E., Goldberg, R. B., Mather, K. J., Marcovina, S. M., Montez, M., Ratner, R. E. et al. · 2013 · Diabetic Medicine
58. A Randomized Trial of Intensive versus Standard Blood-Pressure Control
    The SPRINT Research Group · 2015 · New England Journal of Medicine